.svg){kind=small}
Aug-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
The Tablet has shown a consistent performance in the Capsules category within California. Over the months from May to August 2025, the brand maintained a steady rank of 11th place until it improved to 9th place in August. This upward movement is indicative of a positive trend in market presence and consumer preference. The sales figures over these months reflect this growth, with a noticeable increase from $46,139 in May to $57,732 in August. Such a trajectory suggests that The Tablet is effectively capturing a larger share of the market and enhancing its brand recognition in California.
Beyond California, The Tablet's performance across other states and categories provides a mixed picture. The absence of rankings in other states or categories, implying that The Tablet did not make it into the top 30, could be seen as a potential area for improvement. This lack of presence outside California might suggest that the brand is highly localized or that it faces stiff competition in other markets. Identifying the factors that contribute to its success in California could offer insights into strategies for expanding its footprint in other regions. Understanding these dynamics is crucial for The Tablet as it seeks to broaden its influence and improve its standings across a wider geographical area.
Competitive Landscape
In the competitive landscape of the California cannabis capsules market, The Tablet has shown a promising upward trend in its rankings over the summer of 2025. Starting from the 11th position in May, The Tablet maintained this rank through July before climbing to the 9th position in August. This improvement in rank suggests a positive reception and growing consumer interest, contrasting with competitors like Care By Design, which slipped from 9th to 11th place, and Proof, which fluctuated between 9th and 10th place. Meanwhile, Papa & Barkley held steady at the 8th position, indicating a strong market presence. Despite Emerald Bay Extracts maintaining a higher rank, their sales have shown a declining trend, which could signal potential opportunities for The Tablet to capture more market share. Overall, The Tablet's strategic positioning and consistent sales growth highlight its potential to further ascend in the competitive rankings.
Notable Products
In August 2025, The Tablet's top-performing products were Sativa Tablets 20-Pack (1000mg) and XTabs - Sativa High Dose Tablets 50-Pack (1000mg), both securing the first rank. Notably, Sativa Tablets 20-Pack maintained its leading position from May and June, briefly dropping to second in July, while XTabs - Sativa High Dose climbed back to the top from first in July. Indica Tablets 20-Pack (1000mg) held steady at second position, demonstrating consistent popularity. XTabs - Indica High Dose Tablets 50-Pack (1000mg) improved its rank to third, showing a positive trend in sales. Sativa Tablets 20-Pack recorded a sales figure of 424 units in August, highlighting its strong market presence.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
